After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
SGMT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Sagimet Biosciences Inc is $226.99M. A total of 3.84 million shares were traded on the day, compared to an average of 1.24M shares.
In the most recent transaction, Kemble George sold 23,625 shares of SGMT for 3.17 per share on Jul 23 ’24. After the transaction, the Executive Chairman now owns 118,693 company shares. In a previous transaction on Jul 19 ’24, Martins Eduardo Bruno sold 8,357 shares at 3.10 per share. SGMT shares that Chief Medical Officer owns now total 81,213.
Among the insiders who sold shares, Rozek Elizabeth disposed of 10,914 shares on Jul 19 ’24 at a per-share price of $3.10. This resulted in the General Counsel and CCO holding 160,506 shares of SGMT after the transaction. In another insider transaction, Kemble George sold 14,062 shares at $3.10 per share on Jul 19 ’24. Company shares held by the Executive Chairman now total 142,318.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, SGMT has a high of $9.60 and a low of $1.73.
As of this writing, SGMT has an earnings estimate of -$0.49 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.24 per share and a lower estimate of -$0.72.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. SGMT’s latest balance sheet shows that the firm has $56.73M in Cash & Short Term Investments as of fiscal 2021. There were $348.00k in debt and $2.44M in liabilities at the time. Its Book Value Per Share was $4.32, while its Total Shareholder’s Equity was -$158.26M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SGMT is Buy with a score of 4.75.
